Miri Halperin Wernli left Actelion Pharmaceuticals while Vice President in June 2016 - She worked there for 14 years... There is no way she didn't have a hand in helping getting the JNJ connection and getting the company bought out.
👍︎ 39
💬︎
👤︎ u/twiggs462
📅︎ Jan 04 2022
🚨︎ report
The company Actelion (now Idorsia) developed a drug (Selexipag (Uptravi®) for the treatment of pulmonary arterial hypertension (PAH). See how the cell relaxes after the drug is added. Impressive! v.redd.it/vy8wmi2f25k21
👍︎ 26
💬︎
👤︎ u/pollisa_85
📅︎ Mar 05 2019
🚨︎ report
Drug Maker Actelion Agrees to Pay $360 Million to Resolve False Claims Act Liability for Paying Kickbacks justice.gov/opa/pr/drug-m…
👍︎ 13
💬︎
📅︎ Dec 06 2018
🚨︎ report
The company Actelion (now Idorsia) developed a drug (Selexipag (Uptravi®) for the treatment of pulmonary arterial hypertension (PAH). See how the cell relaxes after the drug is added. Impressive! v.redd.it/vy8wmi2f25k21
👍︎ 21
💬︎
👤︎ u/pollisa_85
📅︎ Mar 04 2019
🚨︎ report
Recent Advancement & Scope in Endothelin Receptor Antagonist Market 2026 Overview by Key players Pfizer Inc., Actelion Pharmaceuticals Ltd., etc.

Endothelin Receptor Antagonist Market Outlooks 2019

https://preview.redd.it/ucwhgcuuk2431.jpg?width=700&format=pjpg&auto=webp&s=8394c2745cd55f6d27d83d2dd26c0e065104cb48

Endothelin Receptor Antagonist Market report is the most important research for who looks for complete information on Endothelin Receptor Antagonist markets. The report covers all information on the Global and regional markets including old and future trends for market demand, size, trading, supply, competitors, and prices as well as Global predominant vendors’ information. the report also provides a complete overview of Endothelin Receptor Antagonist markets; including Top Players or vendors, application, Type, Share, and latest market trends.

The report has been prepared based on the synthesis, analysis, and interpretation of information about Endothelin Receptor Antagonist market collected from specialized sources. The competitive landscape section of the report provides a clear insight into the market share analysis of key industry players.

Click the link to Get a Free Sample Copy of the Report @ https://www.acquiremarketresearch.com/sample-request/93325/

Moreover, Porter's Five Forces Analysis (potential entrants, suppliers, substitutes, buyers, industry competitors) provides crucial information for knowing the Endothelin Receptor Antagonist market.

Major players in the global Endothelin Receptor Antagonist market include:
Merck & Co. Inc
Arena Pharmaceuticals Inc.
Pfizer Inc.
Actelion Pharmaceuticals Ltd.
Bayer AG
SteadyMed Ltd.
United Therapeutics Corporation
Gilead sciences
Reata Pharmaceuticals Inc.
GlaxoSmithKline plc

On the basis of applications, the market covers:
Health care
Clinic
Hospital

Endothelin Receptor Antagonist Market

Company overview, financial overview, product portfolio, new project launched, recent development analysis are the parameters included in the profile. The study then describes the drivers and restraints for the market along with the impact they have on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the market on a global level. Finally, the report in order to meet the user’s requirements is also available.

The report also presents the histori

... keep reading on reddit ➡

👍︎ 2
💬︎
👤︎ u/amrsiasia
📅︎ Jun 13 2019
🚨︎ report

Please note that this site uses cookies to personalise content and adverts, to provide social media features, and to analyse web traffic. Click here for more information.